Valeria Paradies

Valeria Paradies

Interventional cardiologist / Cardiologist
Maasstad Hospital - Rotterdam, Netherlands

Co-chair EAPCI Women Commitee

Latest contributions

Best companion's case on intravascular lithotripsy

23 May 2025 – From EuroPCR 2025

Join this session focusing on intravascular lithotripsy in challenging cases, emphasizing device and drug synergy, IVUS guidance, and strategies to avoid exacerbating complications. Clinical cases demonstrate management of tough calcified lesions with novel approaches.

Best companion's case on intravascular lithotripsy

Novel Hertz Contact Intravascular Lithotripsy: could we achieve more in calcium modification?

22 May 2025 – From EuroPCR 2025

Discover how the novel Hertz Contact Intravascular Lithotripsy (IVL) is pushing the boundaries of calcium modification in challenging coronary lesions.

This EuroPCR 2025 session shares real-world insights confirming the promising results of the PINNACLE I trial, with LithiX IVL proving safe and effective across eccentric, concentric, and...

Novel Hertz Contact Intravascular Lithotripsy: could we achieve more in calcium modification?

The role of DCB in non-left main true bifurcations

22 May 2025 – From EuroPCR 2025

This session offers a detailed exploration of drug-coated balloon (DCB) use in non-left main true bifurcation lesions. Learn to define suitable lesion characteristics for provisional stenting, understand stepwise procedural strategies minimizing implanted material, and appreciate the role of intravascular imaging in assessing bifurcation complexity and optimizing...

The role of DCB in non-left main true bifurcations

Complex PCI for stent failure: LIVE Educational Case from Hospital Clínico San Carlos - Madrid, Spain

21 May 2025 – From EuroPCR 2025

This live educational case from Hospital Clínico San Carlos, Madrid, offers an in-depth look at complex PCI for stent failure. Learn how intracoronary imaging identifies failure mechanisms, guides treatment of recurrent restenosis, and explores drug-coated balloon options to optimize patient outcomes.

Antithrombotic drugs for acute coronary syndromes in women

21 May 2025 – From EuroPCR 2025

Enhance your understanding of antithrombotic drug management in women with acute coronary syndromes (ACS). This session addresses risk stratification balancing ischemic and bleeding risks, evidence-based tailored antithrombotic and revascularisation strategies in high bleeding risk patients, and diagnostic and treatment approaches for MINOCA, with illustrative cases highlighting...

Antithrombotic drugs for acute coronary syndromes in women

Optimal management of high bleeding risk patient with multivessel disease

21 May 2025 – From EuroPCR 2025

This session offers a comprehensive overview of the management of high bleeding risk (HBR) patients with multivessel disease. Through expert discussion and a live case demonstration featuring a complex elderly patient, it highlights how intracoronary imaging and physiology can guide procedural decisions and improve outcomes in this...

Optimal management of high bleeding risk patient with multivessel disease

Complex calcified lesions: combination of intravascular imaging and orbital atherectomy for optimal outcomes

20 May 2025 – From EuroPCR 2025

In this EuroPCR 2025 session on complex calcified coronary lesions, follow a step-by-step analysis of a recorded case structured in three key phases: lesion assessment with OCT, PCI using orbital atherectomy, and post-PCI optimisation with follow-up OCT imaging. Gain valuable insights into managing severely calcified lesions,...

Complex calcified lesions: combination of intravascular imaging and orbital atherectomy for optimal outcomes

Effective techniques for performing DCB angioplasty

16 Jan 2025

Drug-coated balloon (DCB) angioplasty has become a valuable alternative to drug-eluting stents in treating coronary artery disease. To achieve optimal outcomes, proper lesion preparation and techniques to minimise drug loss are crucial.

This article highlights key steps and best practices for performing DCB angioplasty, ensuring effective drug delivery and...

Valeria Paradies

Author

Valeria Paradies

Author

Gianluca Mincione

Completeness of revascularisation in acute coronary syndrome patients with multivessel disease

28 Jun 2024

Explore evidence on complete revascularisation for patients with STEMI or NSTEMI and multivessel disease, and provide insights into the roles of intracoronary guidance by physiology and imaging.

PCR Webinars: Bringing the hot topics in interventional cardiology to your home

10 Jun 2024

According to Medical Director of PCR Webinars, Dejan Milasinovic, two novel additions to the platform will increase the interactive experience and take webinar­ based learning to a new level.

Multivessel disease in ACS - which lesions to treat and when

21 May 2024

Watch the replay of this webinar with S. Biscaglia, V. Paradies and P. Smits on how to learn about new evidence for complete revascularisation in ACS and much more!

Update on coronary physiology in 2024

17 May 2024 – From EuroPCR 2024

This session provides an update on the available options for invasive coronary physiology in 2024. It reviews the latest evidence supporting the clinical adoption of invasive physiology indexes and shares practical tips and tricks for their application. Topics covered include CT-based physiology, pressure wire-based physiology, angiography-based...

Update on coronary physiology in 2024

PCI to treat the bystander disease in STEMI patients: who, when and how?

16 May 2024 – From EuroPCR 2024

Watch this case-based session on PCI for STEMI to see how the guidelines are influenced by the COMPLETE trial. Learn why and how physiology can guide intermediate lesions, the importance of intracoronary imaging guidance, the value of complete revascularization in STEMI patients, the optimal method for...

PCI to treat the bystander disease in STEMI patients: who, when and how?

Trial updates and featured clinical research

16 May 2024 – From EuroPCR 2024

This session showcases a selection of the latest clinical research and trial updates presented at EuroPCR 2024. Attendees will have the opportunity to learn about the findings from studies evaluating the use of OCT-guided PCI for chronic total occlusions, the safety and efficacy of short dual...

Trial updates and featured clinical research

Management of patient with coronary artery disease and left ventricle dysfunction

15 May 2024 – From EuroPCR 2024

This session focuses on the management of patients with stable coronary artery disease and left ventricular dysfunction. Experts will discuss the role of mechanical circulatory support devices in these patients, as well as the diagnosis and treatment of microvascular angina, which can be a challenging complication...

Management of patient with coronary artery disease and left ventricle dysfunction

Cracking the calcium code - Novelty and utility of Hertz Contact intravascular lithotripsy

15 May 2024 – From EuroPCR 2024

Follow this session to learn about the novel HC-IVL system, its application for moderate to severe calcified lesions, and procedural tips. The LithiX Hertz Contact IVL addresses unmet needs in coronary artery calcification by offering a simplified workflow with fewer devices and effective treatment for difficult...

Cracking the calcium code - Novelty and utility of Hertz Contact intravascular lithotripsy

Randomised trials: substudies and extended follow-up - A quick update

15 May 2024 – From EuroPCR 2024

This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...

Randomised trials: substudies and extended follow-up - A quick update

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

14 May 2024 – From EuroPCR 2024

Discover the remarkable performance of Supraflex Cruz in real-world clinical settings, showcasing exceptionally low event rates and demonstrating its safety and efficacy across a spectrum of high-risk patients, including the elderly and those with high bleeding risks, and delve into the ongoing TALENT and TUDEXO II...

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

Role of deferred stenting in culprit and non-culprit lesions for STEMI

14 May 2024 – From EuroPCR 2024

This session explores the role of deferred stenting in STEMI patients, covering when and how PCI can be deferred, the latest pharmacological options for deferred stenting, and the use of imaging and physiology to guide revascularization in a primary PCI setting. Through case presentations and discussions,...

Role of deferred stenting in culprit and non-culprit lesions for STEMI

What is the optimal management of patients with coronary artery disease and left ventricle dysfunction in 2024?

15 May 2024 – From EuroPCR 2024

Check out this EuroPCR 2024 interview between Valeria Paradies and Vasileios Panoulas to learn about CAD patients with LV dysfunction. Gain insights from the REVIVED trial, which shows that very stable, asymptomatic patients can be treated with medical therapy, including the four pillars of heart failure...

What is the optimal management of patients with coronary artery disease and left ventricle dysfunction in 2024?

Stent failure management - Contemporary management options - Part 2

18 May 2023 – From EuroPCR 2023

In this session, explore the evolving causes of restenosis in contemporary practice and understand how to tailor in-stent restenosis treatment based on its underlying mechanism. Discover why imaging is crucial for selecting the appropriate treatment in cases of in-stent restenosis, and learn that drug-coated balloons are...

Stent failure management - Contemporary management options - Part 2

Emerging indications for TAVI

18 May 2023 – From EuroPCR 2023

Consult this session if you want to learn about emergent indications of transcatheter treatment of aortic valve disease, to appreciate current gaps in the evidence base and hear about upcoming clinical trials, and to highlight new technologies that will address these treatment gaps.

Emerging indications for TAVI

How should I treat non-culprit lesions in a patient with STEMI

17 May 2023 – From EuroPCR 2023

You wonder whether complete revascularisation for STEMI patients is beneficial? You want to know how to assess non-culprit lesions? You wonder about the optimal timing for treating non-culprit lesions? You would like to be able to do more for STEMI patients? Then, this session replay is...

How should I treat non-culprit lesions in a patient with STEMI

What is the role of mechanical circulatory support in cardiogenic shock in patient with AMI?

17 May 2023 – From EuroPCR 2023

Shrilla Banerjee and Valeria Paradies were invited to talk about a subject that was very often raised during EuroPCR 2023: how to save both the patient and the myocardium in case of cardiogenic shock?

As there is currently little evidence of the benefits of mechanical circulatory assistance, which...

What is the role of mechanical circulatory support in cardiogenic shock in patient with AMI?

Managing cardiogenic shock in patients with AMI

16 May 2023 – From EuroPCR 2023

In this session, study the case of a 78-year-old male patient with HTN presenting with subtotal and thrombotic lesion of LMCA ostium and significant lesion at LMCA bifurcation with involvement of prox RCX and prox LAD and find out how he was treated.

Managing cardiogenic shock in patients with AMI

My patient with STEMI

15 May 2023 – From EAPCI-PCR Fellows course 2023

Consult these slides to understand the challenges of primary PCI, to discuss contemporary approaches to multivessel PCI in STEMI and to learn how to prevent and manage complications during primary PCI.

My patient with STEMI

Stent failure and intravascular imaging: shedding the light to improve outcomes

20 May 2022 – From EuroPCR 2022

Understand how to use intravascular imaging to analyse the reasons for stent failure (restenosis and/or thrombosis) by viewing these 2 cases shared by your peers: 1 focusing on OCT & the other on IVUS.

Stent failure and intravascular imaging: shedding the light to improve outcomes

What's new in left main PCI - a closer look on the provisional vs. upfront two-stent strategy

19 May 2022 – From EuroPCR 2022

Treatment dilemma: how should I treat an isolated CX or LAD stenosis

19 May 2022 – From EuroPCR 2022

Daily news

19 May 2022 – From EuroPCR 2022